Radiesse (+) Lidocaine - Dermal tissue reconstructive material, synthetic mineral, anaesthetic

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Available from:

Merz Australia Pty Ltd

Class:

Class III

Manufactured by:

Merz North America Inc 4133 Courtney Road Suite 10, Franksville, WI, 53126 United States Of America

Therapeutic area:

62574 - Dermal tissue reconstructive material, synthetic mineral, anaesthetic

Therapeutic indications:

RADIESSE (+) Lidocaine injectable implant is a sterile semi solid implant of suspended synthetic calcium hydroxylapatite in a gel carrier of sterile water for injection, glycerin, sodium carboxymethylcellulose, and 0.3% lidocaine. The gel is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection. Pack contains 1 sterile 0.8mL or 1.5mL syringe and 2 sterile 27G 0.75" needles. Radiesse (+) Lidocaine Injectable Implant is indicated for plastic / reconstructive procedures, including deep dermal and subdermal soft tissue augmentation of the facial area and is also intended for restoration and correction of fat or volume loss (lipoatrophy) in the facial area and for rejuvenation of the hands.

Authorization status:

A

Authorization date:

2018-03-10